Cleared Traditional

K150064 - Synthetic Bone Graft (TriPore HA, TriPore BP90, TriPore BP15)

K150064 is an FDA 510(k) clearance for Synthetic Bone Graft (TriPore HA, manufactured by Orthogem, Ltd.. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 234-day FDA review.

K150064 · Orthogem, Ltd. · Orthopedic device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2015
Decision
234d
Days
Class 2
Risk

K150064 is an FDA 510(k) clearance for the Synthetic Bone Graft (TriPore HA, TriPore BP90, TriPore BP15). Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Orthogem, Ltd. (Nottingham, GB). The FDA issued a Cleared decision on September 4, 2015 after a review of 234 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K150064

510(k) Number K150064 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 13, 2015
Decision Date September 04, 2015
Days to Decision 234 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
112d slower than avg
Panel avg: 122d · This submission: 234d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Priory Analysts, Ltd.
ROD RUSTON

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 492
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K150064.
Bio2 CLM BG Bioactive Scaffold
K152589 · Bio2 Technologies, Inc. · Jan 2016
FIBERGRAFT BG Morsels
K151154 · Prosidyan, Inc. · Nov 2015
AttraX Putty
K151584 · Progentix Orthobiology BV · Oct 2015
NovaBone MacroFORM MIS Composite - 2.5cc, NovaBone MIS Cartridge Delivery System (cartridge handle only)
K152071 · Novabone Products, LLC · Aug 2015
GranOSTM - beta tricalcium phosphate synthetic bone granules
K143692 · Tcm Associates, Ltd. · Aug 2015
OsteoSelect PLUS Demineralized Bone Matrix Putty
K150621 · Bacterin International, Inc. · Aug 2015